Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 LDL Cholesterol, hsCRP, and Clinical Outcomes on Statin Therapy
Cumulative rates of recurrent myocardial infarction or cardiovascular death among statin-treated patients according to achieved levels of LDL cholesterol in mg/dl and achieved levels of hsCRP in mg/l in the PROVE-IT–TIMI-22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction-22) trial (left) and in the A to Z (Aggrastat to Zocor) trial (right). Data adapted from references 77 and 80. hsCRP = high-sensitivity C-reactive protein; LDL = low-density lipoprotein.
